Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
TET protein inhibitors: Potential and limitations.
Kaplánek R, Kejík Z, Hajduch J, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hosnedlová B, Hromádka R, Dytrych P, Novotný P, Abramenko N, Antonyová V, Hoskovec D, Babula P, Masařík M, Martásek P, Jakubek M. Kaplánek R, et al. Among authors: abramenko n. Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. Epub 2023 Aug 18. Biomed Pharmacother. 2023. PMID: 37598475 Free article. Review.
Non-psychotropic cannabinoids as inhibitors of TET1 protein.
Antonyová V, Kejík Z, Brogyanyi T, Kaplánek R, Veselá K, Abramenko N, Ocelka T, Masařík M, Matkowski A, Gburek J, Abel R, Goede A, Preissner R, Novotný P, Jakubek M. Antonyová V, et al. Among authors: abramenko n. Bioorg Chem. 2022 Jul;124:105793. doi: 10.1016/j.bioorg.2022.105793. Epub 2022 Apr 6. Bioorg Chem. 2022. PMID: 35462234
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design.
Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Kejík Z, et al. Among authors: abramenko n. Pharmaceutics. 2021 Nov 5;13(11):1879. doi: 10.3390/pharmaceutics13111879. Pharmaceutics. 2021. PMID: 34834295 Free PMC article. Review.
Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators.
Antonyová V, Tatar A, Brogyányi T, Kejík Z, Kaplánek R, Vellieux F, Abramenko N, Sinica A, Hajduch J, Novotný P, Masters BS, Martásek P, Jakubek M. Antonyová V, et al. Among authors: abramenko n. Int J Mol Sci. 2022 Sep 16;23(18):10850. doi: 10.3390/ijms231810850. Int J Mol Sci. 2022. PMID: 36142763 Free PMC article.
Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting.
Kejík Z, Koubková N, Krčová L, Sýkora D, Abramenko N, Veselá K, Kaplánek R, Hajduch J, Houdová Megová M, Bušek P, Šedo A, Lacina L, Smetana K Jr, Martásek P, Jakubek M. Kejík Z, et al. Among authors: abramenko n. Bioorg Chem. 2023 Dec;141:106816. doi: 10.1016/j.bioorg.2023.106816. Epub 2023 Sep 9. Bioorg Chem. 2023. PMID: 37716274 Free article.
Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
Brogyányi T, Kaplánek R, Kejík Z, Hosnedlová B, Antonyová V, Abramenko N, Veselá K, Martásek P, Vokurka M, Richardson DR, Jakubek M. Brogyányi T, et al. Among authors: abramenko n. Biomed Pharmacother. 2022 Nov;155:113736. doi: 10.1016/j.biopha.2022.113736. Epub 2022 Sep 23. Biomed Pharmacother. 2022. PMID: 36156366 Free article.
Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration.
Fialova JL, Hönigova K, Raudenska M, Miksatkova L, Zobalova R, Navratil J, Šmigová J, Moturu TR, Vicar T, Balvan J, Vesela K, Abramenko N, Kejik Z, Kaplanek R, Gumulec J, Rosel D, Martasek P, Brábek J, Jakubek M, Neuzil J, Masarik M. Fialova JL, et al. Among authors: abramenko n. Biomed Pharmacother. 2022 Oct;154:113582. doi: 10.1016/j.biopha.2022.113582. Epub 2022 Aug 30. Biomed Pharmacother. 2022. PMID: 36055111 Free article.
New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.
Talianová V, Kejík Z, Kaplánek R, Veselá K, Abramenko N, Lacina L, Strnadová K, Dvořánková B, Martásek P, Masařík M, Megová MH, Bušek P, Křížová J, Zdražilová L, Hansíková H, Vlčák E, Filimonenko V, Šedo A, Smetana K Jr, Jakubek M. Talianová V, et al. Among authors: abramenko n. Pharmaceutics. 2022 Aug 17;14(8):1712. doi: 10.3390/pharmaceutics14081712. Pharmaceutics. 2022. PMID: 36015338 Free PMC article.
12 results